Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × vistusertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 3 Stomach Neoplasms 2 Solid Tumor 2 Small Cell Lung Carcinoma 2 Recurrence 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Neoplasm Metastasis 1 Muscle Invasive Bladder Cancer 1 Meningioma 1 Lung Neoplasms 1 Glioblastoma 1 Estrogen Receptor Positive Breast Cancer 1 Endometrial Neoplasms 1 Disease 1 DLBCL 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma 1 Advanced Solid Malignancies 1 Advanced Metastatic Breast Cancer 1 Advanced Cancer 1 Adenocarcinoma 1

Interventions

Blood Specimen Collection 8 Surveys and Questionnaires 6 Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Mammography 5 Cyclophosphamide 5 Colonoscopy 5 Biopsy 5 Prednisone 4 Positron Emission Tomography Computed Tomography 4 Magnetic Resonance Imaging 4 Lenalidomide 4 Biopsy, Fine-Needle 4 Tomography, X-Ray Computed 3 Surgical Procedures, Operative 3 Melphalan 3 Liquid Biopsy 3 Interviews as Topic 3 Diagnostic Tests, Routine 3 weifuchun 2 pembrolizumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Urination 2 Preoperative Exercise 2 Positron-Emission Tomography 2 Methods 2 Injections 2 Immunohistochemistry 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02064608 2019-07-17

CaNCaP02

Cambridge University Hospitals NHS Foundation Trust

Phase 1 Completed

Disease, Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡